Suspension of trading
Consensus Decoy Therapeutics Inc. Börse Stuttgart
Stocks
FP11
US79400X6022
Biotechnology & Medical Research
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 3.104 EUR | -3.96% |
|
+704.15% | +435.17% |
| 07-15 | Decoy Therapeutics Inc. Elects Patricia Gauthier as Class II Director | CI |
| 07-10 | Decoy Therapeutics Files to Register Up to 3.77 Million Shares for Resale | MT |
Evolution of the Average Target: Decoy Therapeutics Inc.
Evolution of the Target Price: Decoy Therapeutics Inc.
Changes in Analyst Recommendations: Decoy Therapeutics Inc.
f0c84ed6c3c7bf.7Z9dxbMmIQbchA996p4-fLkpXtJ4j8RSXTTdnDQoO5o.vNEeodxxbGedt2I6osoHEt5rZ7lP27YwGlDk6EdFQ_TVqzuP3RNkcZ7jSg~2ab2e0120d911de68a92d2ed1b023e4c
| Consensus | Analysts' recommendations evolution (4 months) | Financial estimates divergence | Analysts' Target price divergence | Objective/dr gap | ||
|---|---|---|---|---|---|---|
 | +15.84% | |||||
| +27.64% | |||||
| +81.3% | |||||
| +33.1% | |||||
| +27.13% | |||||
| +24.84% | |||||
| -10.18% | |||||
| +14.72% | |||||
| -8.92% | |||||
| Average | +22.83% | |||||
| Weighted average by Cap. | +25.12% |
Analysts' Consensus
Sell
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
5.305USD
Average target price
30.00USD
Spread / Average Target
+465.50%
High Price Target
30.00USD
Spread / Highest target
+465.50%
Low Price Target
30.00USD
Spread / Lowest Target
+465.50%
Analyst Consensus Detail
Consensus revision (last 18 months)
Analysts covering the company
| Ladenburg Thalmann | |
| HC Wainwright |
SellBuy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
5.305USD
Average target price
30.00USD
Spread / Average Target
+465.50%
Annual profits - Rate of surprise
- Stock Market
- Stocks
- DCOY Stock
- FP11 Stock
- Consensus Decoy Therapeutics Inc.
Select your edition
All financial news and data tailored to specific country editions
